Former British prime minister David Cameron hailed Tata Motors' takeover of Jaguar Land Rover, calling it a "big moment".

The stock of small-cap biotech Jaguar Health Inc. rose 7% on Wednesday, after the company launched its gelclair treatment for ...

This product represents the third prescription solution commercialized by Jaguar's family company, Napo Pharmaceuticals. Oral mucositis, often referred to as "chemo mouth," is a significant ...

Gelclair ® is the company's third commercialized prescription product Oral mucositis, also called "chemo mouth," a painful inflammation of the mouth's mucous membranes, has emerged as the most ...

Swarna Ramanathan joins the automaker from McKinsey, where she was a leader in the company’s automotive and assembly division ...

The stock of small-cap biotech Jaguar Health Inc. rose 3% on Wednesday, after the company launched its gelclair treatment for oral mucositis, a common side effect suffered by head and neck cancer ...

This product represents the third prescription solution commercialized by Jaguar's family company, Napo Pharmaceuticals. Oral mucositis, often referred to as "chemo mouth," is a significant adverse ...

Jaguar Land Rover India reports a 36% increase in SUV sales for FY2025, driven by strong demand for Range Rover and Defender ...

Ratan Tata's formula for managing international acquisitions found success with Tetley and JLR; but his track record suffered ...

旧金山 - Jaguar Health, Inc. (NASDAQ:JAGX)宣布在美国商业推出Gelclair,这是一种获FDA批准的口腔黏膜炎治疗产品。口腔黏膜炎是癌症治疗的一种常见且痛苦的副作用。Gelclair是Jaguar旗下公司Napo Pharmaceuticals商业化的第三种处方解决方案。 口腔黏膜炎,通常被称为"化疗口腔",是肿瘤学中一种重要的不良事件,会导致口腔疼痛性炎症,影 ...